FDA Inspection
VitalantVitalant – FDA Inspection, May 24, 2012
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on May 24, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- May 24, 2012
- Product Type
- Biologics
View Company Profile
ID · 23f95a46-c438-40d3-837f-613ace1fbe18
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 782960
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2025 | Not classified | Cincinnati District Office | |
| May 18, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 7, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 25, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 20, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1259448 - 2025-01-24
- FDA Inspection 1142856 - 2021-05-18
- FDA Inspection 1056338 - 2018-06-07
- FDA Inspection 972547 - 2016-05-25
- FDA Inspection 871038 - 2014-03-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.